The regulatory approval process with the U.S. Food and Drug Administration has commenced for Innocan’s LPT-CBD release technology, marking a key step in the advancement of non-opioid pain management

HERZLIYA, Israel and CALGARY, AB, May 21, 2024 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), is pleased to announce significant advancements in the regulatory process for its Liposome-Cannabidiol (LPT-CBD) technology, which provides an innovative solution in non-opioid pain management. The U.S. Food and Drug Administration (“FDA”) has granted Innocan an Investigational New Drug (“IND”) number and approved an initial meeting with the Company to discuss the strategic path forward.

The meeting with the FDA has been set for July 31, 2024, where Innocan will present its preclinical results and proposed clinical development plan. This meeting is key to launching human clinical trials for the LPT-CBD injectable drug, developed to provide a novel treatment option for chronic pain.

“We are very pleased with this crucial step towards launching our IND program for LPT-CBD in the United States,” commented Iris Bincovich CEO of Innocan Pharma. “This upcoming FDA consultation is pivotal, poised to set the stage for our clinical trials and drive forward our mission to revolutionize pain management. We look forward to the FDA reviewing our development program and providing us with guidance on our advancement to human clinical trials.”

Continued Iris Bincovich, CEO, “I thank Prof. Chezy Barenholz and Dr. Ahuva Cern of the Hebrew University of Jerusalem, renowned experts in liposome research, for their continued efforts providing strong supportive data on LPT-CBD, enabling our upcoming engagement with FDA.”

LPT therapy, which requires only one single monthly subcutaneous injection, offers a groundbreaking alternative to opioid-based approaches. Addressing the critical opioid crisis, where, according to the U.S. Centers for Disease Control and Prevention, over three-quarters of drug overdose deaths in the U.S. involve opioids, Innocan’s LPT-CBD presents a compelling, life-saving alternative. In multiple pre-clinical trials, Innocan’s therapy has shown consistent efficacy of its LPT-CBD injectable treatment, through prolonged and controlled release of CBD in animals with chronic pain conditions.

About Innocan

Innocan is a pharmaceutical tech company that operates under two main segments: Pharmaceuticals and Consumer Wellness. In the Pharmaceuticals segment, Innocan focuses on developing innovative drug delivery platform technologies based on advanced cannabinoids science, to treat various conditions to improve patients’ quality of life. This segment involves two drug delivery technologies: (i) LPT CBD- loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. The LPT delivery platform research is in the preclinical trial phase for: Pain Management. In the Consumer Wellness segment, Innocan develops and markets a wide portfolio of innovative and high-performance self-care products to promote a healthier lifestyle. Under this segment, Innocan has established a joint venture by the name of BI Sky Global Ltd. that focuses on advanced targeted online sales. https://innocanpharma.com/

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO

+1-516-210-4025

+972-54-3012842

+442037699377
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Cautionary note regarding forward-looking information

Certain information set forth in this news release, including, without limitation, information regarding research and development, collaborations, the filing of potential applications with the FDA and other regulatory authorities, the potential achievement of future regulatory milestones, the potential for treatment of conditions and other therapeutic effects resulting from research activities and/or the Company’s products, requisite regulatory approvals and the timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Logo – https://mma.prnewswire.com/media/2046271/3968398/Innocan_Pharma_Corporation_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/fda-has-granted-innocan-pharma-a-meeting-date-for-lpt-cbd-for-chronic-pain-302151667.html

As the inaugural London conference commenced today, attendees heard from industry experts who shed light on Revenue Generation with Blockchain

LONDON, May 21, 2024 /PRNewswire/ — Attendees at the London Blockchain Conference experienced an enlightening first day, kickstarting with informative and thought-provoking speakers, discussing a wide range of topics involving Digital Currency and government policy, trust economy, carbon offset derivatives using blockchain and smart contracts. 

Day 1 of the conference focused on ‘Rev-gen with Blockchain’. The agenda was filled with engaging sessions and discussions that delved into various topics like the Evolution of Web 3 and its impact on the Finance Sector. Attendees also had the opportunity to explore the transformative potential of blockchain technology in areas such as data integrity, accountability, and trust for customers and users. Other notable sessions shed light on the revolutionary role of blockchain in combating counterfeit goods, stable coins, and the Future of Blockchain tokens. 

Throughout the day attendees heard from distinguished speakers who brought their expertise to the forefront.

Blockchain 101 session by Connor Murray, Director of Stewardship at BSV Association who opened the conference by explaining how blockchain technology introduces a new way of interacting with applications and services that have become integral to our digitally connected world.

The keynote speaker for Day 1 was Scott Galloway, Professor of Marketing at NYU Stern School of Business /Entrepreneur who shared his predictions on future trends, analysing the economy, Web3 ecosystem and AI’s transformative potential. He highlighted the products and trends that are receiving too much vs too little attention and investment.

Cybersecurity Future: Blockchain’s Role in Enhanced Security – a panel moderated by John Velossariis, Founder & Director, Otranto Limited, with speakers Joseph Kearney, Research Associate, University of Kent / Block Sphere, and Robert Huber, Tech Lead, Veridat, where they discussed blockchain’s impact on cybersecurity, including decentralised identity management, supply chain security, smart contracts, and DDoS attack defences.

How Teranode delivers blockchain scaling for Enterprise use – Siggi Oskarsson, Director of Teranode at BSV Blockchain, Jordan Kramsky, Solutions Architect at AWS and Behrad Babaee, Principal Architect at Aerospike discussed the pivotal role of Teranode in driving enterprise-level adoption of the BSV blockchain and is poised to revolutionise the blockchain landscape and unlock new possibilities for businesses worldwide.

Owen Vaughan, Chief Scientist Officer at nChain in his session titled, ‘What if your blockchain is different to mine?’, explained the role of Web3 and Blockchain and building a decentralised online ecosystem. He also presented nChain’s Universal Blockchain Assets (UBA) Wallet for interoperable blockchain tokens across other chains.

Tokenisation and the Wine Industry – Steven Bacci, Principal Worldwide Specialist Solutions Architect, AWS and David Garrett, Managing Partner, dVIN discussed how blockchain enhances transparency, and security, offers anti-fraud solutions, and supply chain efficiency and fosters a global community of wine lovers and producers. They also highlighted how dVIN leverages AWS-managed blockchain for innovation and market acceleration.

Solving Blockchain’s Interoperability Challenges – Moderated by Becky Liggero, Reporter, Producer and Host at Coingeek, the panellists Irina Benfrid, B2B Partnerships Lead, Rubic Finance, Clem Chambers, CEO, Online Blockchain, Evelyn Nomaya, PhD Researcher, Trinity College and Ty Everett, Founding President, Project Babbage, focused on solving blockchain’s interoperability challenges and how addressing these interoperability issues is paramount for unleashing the full potential of blockchain technology.  

Establishing Trust in AI: Blockchain – Scott Zoldi, Chief Analytics Officer at FICO, highlighted the critical role of blockchain in enforcing and proving Responsible AI practices. He stressed that the responsible use of AI is vital to society and must go beyond just pledges and ethics committees to ensure genuine accountability.

Please register here if you would like to attend or listen to any of the sessions today. 

About the London Blockchain Conference

NETWORK. LEARN. ENGAGE. 

At the London Blockchain Conference, we show how Blockchain will change the world and help people see another way to manage data, build scalable on-chain solutions and achieve great things. We do this by creating valuable, insightful, and engaging events that educate and inform, allowing you to connect and network to build strong business relationships. Our conference is the best avenue to see blockchain innovations, ecosystem announcements, product launches, technology updates, keynote speeches, panels, and fireside chats from blockchain leaders. Join us and experience it for yourself. 

View original content:https://www.prnewswire.co.uk/news-releases/london-blockchain-conference-day-1-highlights-302151978.html

DOHA, Qatar, May 21, 2024 /PRNewswire/ — The 4th annual Qatar Economic Forum, held May 14 -16 in Doha, concluded on a high note, solidifying its position as a premier platform for navigating the complexities of a rapidly changing global landscape. Powered by Bloomberg and hosted in collaboration with Media City Qatar, the event brought together over 2,700 in-person attendees and boasted a total of 3,592 registrations, including 1,000+ global leaders, CEOs, and 427 government officials from 124 countries.

This year’s edition, held under the theme ‘A World Remade: Navigating the Year of Uncertainty,’ showcased a renewed sense of collaboration and a commitment to addressing the challenges presented by an interconnected world. Globalization and trade, the energy transition, technology and innovation, along with sports and entertainment, and the business and investment outlook, were at the forefront of discussions.

However, fostering collaboration extends beyond the walls of the Forum itself: one of the defining aspects of the event is its unwavering focus on a news-driven approach. The Forum recognizes the media’s critical role in shaping economic, political, and social narratives.  In today’s interconnected world, clear and accurate information is essential for fostering global understanding and cooperation.

The Forum attracted significant media interest, drawing over 160 members of the press from more than 35 media outlets. Over 50 interviews were conducted with key participants, securing prominent coverage across various platforms. The event garnered front-page placement in print publications, featured articles in online media, and prime-time broadcast segments, resulting in hundreds media mentions across 25 countries. This widespread coverage highlights the importance and the impact of the discussions held at the event.

His Excellency Sheikh Dr. Abdulla bin Ali Al Thani, Chairman of Media City Qatar, a key partner of the Forum, emphasized this crucial role.  He highlighted the media’s transformative potential, stressing the need for compelling narratives that not only combat misinformation but also promote understanding across diverse global perspectives.  Through fostering innovation and dialogue, Media City Qatar aims to empower the Gulf’s media industry to become a dynamic force for economic growth and a bridge between cultures. 

The Forum transcended mere rhetoric by witnessing concrete steps toward innovation and collaboration.  The signing of 21 memorandums of understanding (MoUs) stands as a testament to this commitment.  Media City Qatar had two particularly noteworthy partnerships announced at the Forum with Qatar University (QU) and the Qatar Research, Development and Innovation (QRDI) Council.

These notable partnerships are set to pave the way for substantial growth in Qatar’s media sector by enhancing technological capabilities, providing comprehensive training programs, and fostering a conducive environment for innovative media companies. They further underscore Media City Qatar’s commitment to transforming Qatar into a global media hub and creating high-skilled job opportunities in the media industry.

ABOUT MEDIA CITY QATAR

Media City Qatar (MCQ) is an emerging, collaborative global hub for media companies, entrepreneurs, innovators, and creative talent, and a regional leader in the media industry, contributing to Qatar’s economic diversification. It accelerates the evolution of regional media to create a powerful and innovative ecosystem where exceptional ideas and content thrive. Media City Qatar was established to streamline necessary regulations, develop businesses and unlock investment opportunities to support the media ecosystem in Qatar under its regulatory, developmental, and investment mandates.

Media City Qatar aims to foster a nurturing environment and a hub for traditional and digital media, technology, communications, research, and development. From broadcasting to traditional and digital newspapers, from gaming to user-generated content, and enabling AI and advanced technologies. Media City Qatar welcomes media businesses across different media segments of various scales to join.

For more information, visit www.mediacity.qa or follow us on @mediacityqa |#mediacityqatar

Photo – https://mma.prnewswire.com/media/2418443/Media_City_Qatar_1.jpg
Photo – https://mma.prnewswire.com/media/2418444/Media_City_Qatar_2.jpg

View original content:https://www.prnewswire.co.uk/news-releases/the-2024-qatar-economic-forum-powered-by-bloomberg–a-resounding-success-in-news-driven-global-discourse-302151863.html